|
1
|
Kyle RA and Rajkumar SV: Criteria for
diagnosis, staging, risk stratification and response assessment of
multiple myeloma. Leukemia. 23:3–9. 2009. View Article : Google Scholar :
|
|
2
|
Raab MS, Podar K, Breitkreutz I,
Richardson PG and Anderson KC: Multiple myeloma. Lancet.
374:324–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hideshima T, Mitsiades C, Tonon G,
Richardson PG and Anderson KC: Understanding multiple myeloma
pathogenesis in the bone marrow to identify new therapeutic
targets. Nat Rev Cancer. 7:585–598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsu J, Shi Y, Krajewski S, Renner S,
Fisher M, Reed JC, Franke TF and Lichtenstein A: The AKT kinase is
activated in multiple myeloma tumor cells. Blood. 98:2853–2855.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hideshima T, Nakamura N, Chauhan D and
Anderson KC: Biologic sequelae of interleukin-6 induced PI3-K/Akt
signaling in multiple myeloma. Oncogene. 20:5991–6000. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang J, Li Y and Shen B: PI3-K/Akt
pathway contributes to IL-6-dependent growth of 7TD1 cells. Cancer
Cell Int. 3:1–4. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu JH, Shi Y, Hu L, Fisher M, Franke TF
and Lichtenstein A: Role of the AKT kinase in expansion of multiple
myeloma clones: Effects on cytokine-dependent proliferative and
survival responses. Oncogene. 21:1391–1400. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Whiteman M, Le Trionnaire S, Chopra M, Fox
B and Whatmore J: Emerging role of hydrogen sulfide in health and
disease: Critical appraisal of biomarkers and pharmacological
tools. Clin Sci (Lond). 121:459–488. 2011. View Article : Google Scholar
|
|
10
|
Kimura H: Hydrogen sulfide: Its
production, release and functions. Amino Acids. 41:113–121. 2011.
View Article : Google Scholar
|
|
11
|
Szabó C: Hydrogen sulphide and its
therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vandiver M and Snyder SH: Hydrogen
sulfide: A gasotransmitter of clinical relevance. J Mol Med Berl.
90:255–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rose P, Moore PK, Ming SH, Nam OC,
Armstrong JS and Whiteman M: Hydrogen sulfide protects colon cancer
cells from chemopreventative agent beta-phenylethyl isothiocyanate
induced apoptosis. World J Gastroenterol. 11:3990–3997. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sen N, Paul BD, Gadalla MM, Mustafa AK,
Sen T, Xu R, Kim S and Snyder SH: Hydrogen sulfide-linked
sulfhydration of NF-κB mediates its antiapoptotic actions. Mol
Cell. 45:13–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Whiteman M and Moore PK: Hydrogen sulfide
and the vasculature: A novel vasculoprotective entity and regulator
of nitric oxide bioavailability? J Cell Mol Med. 13:488–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Papapetropoulos A, Pyriochou A, Altaany Z,
Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN,
Wang R, et al: Hydrogen sulfide is an endogenous stimulator of
angiogenesis. Proc Natl Acad Sci USA. 106:21972–21977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi KS, Song H, Kim EH, Choi JH, Hong H,
Han YM and Hahm KB: Inhibition of hydrogen sulfide-induced
angiogenesis and inflammation in vascular endothelial cells:
Potential mechanisms of gastric cancer prevention by Korean red
ginseng. J Ginseng Res. 36:135–145. 2012. View Article : Google Scholar
|
|
18
|
Hellmich MR, Coletta C, Chao C and Szabo
C: The therapeutic potential of cystathionine β-synthetase/hydrogen
sulfide inhibition in cancer. Antioxid Redox Signal. 22:424–448.
2015. View Article : Google Scholar :
|
|
19
|
Szabó C and Papapetropoulos A: Hydrogen
sulphide and angiogenesis: Mechanisms and applications. Br J
Pharmacol. 164:853–865. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Attene-Ramos MS, Wagner ED, Plewa MJ and
Gaskins HR: Evidence that hydrogen sulfide is a genotoxic agent.
Mol Cancer Res. 4:9–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Qi Q, Yang J, Sun D, Li C, Xue Y,
Jiang Q, Tian Y, Xu C and Wang R: An anticancer role of hydrogen
sulfide in human gastric cancer cells. Oxid Med Cell Longev.
2015:6364102015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murata T, Sato T, Kamoda T, Moriyama H,
Kumazawa Y and Hanada N: Differential susceptibility to hydrogen
sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer
cell lines and oral keratinocytes: Role of PHLDA1 as an apoptosis
suppressor. Exp Cell Res. 320:247–257. 2014. View Article : Google Scholar
|
|
23
|
Zhen Y, Pan W, Hu F, Wu H, Feng J, Zhang Y
and Chen J: Exogenous hydrogen sulfide exerts
proliferation/anti-apoptosis/angiogenesis/migration effects via
amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma
cells. Int J Oncol. 46:2194–2204. 2015.PubMed/NCBI
|
|
24
|
Kodela R, Nath N, Chattopadhyay M, Nesbitt
DE, Velázquez-Martínez CA and Kashfi K: Hydrogen sulfide-releasing
naproxen suppresses colon cancer cell growth and inhibits NF-κB
signaling. Drug Des Devel Ther. 9:4873–4882. 2015.
|
|
25
|
Kolluru GK, Shen X, Bir SC and Kevil CG:
Hydrogen sulfide chemical biology: Pathophysiological roles and
detection. Nitric Oxide. 35:5–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang R: Physiological implications of
hydrogen sulfide: A whiff exploration that blossomed. Physiol Rev.
92:791–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fernández Y, Gu B, Martínez A, Torregrosa
A and Sierra A: Inhibition of apoptosis in human breast cancer
cells: Role in tumor progression to the metastatic state. Int J
Cancer. 101:317–326. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Younes H, Leleu X, Hatjiharissi E, Moreau
AS, Hideshima T, Richardson P, Anderson KC and Ghobrial IM:
Targeting the phosphatidylinositol 3-kinase pathway in multiple
myeloma. Clin Cancer Res. 13:3771–3775. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai WJ, Wang MJ, Ju LH, Wang C and Zhu YC:
Hydrogen sulfide induces human colon cancer cell proliferation:
Role of Akt, ERK and p21. Cell Biol Int. 34:565–572. 2010.
View Article : Google Scholar : PubMed/NCBI
|
